Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-08-21 Sale | 2023-08-22 12:24 pm | Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks | 1,605 | $7.0419 | $11,302 | 58,357 (Direct) | View |
| 2023-05-31 Sale | 2023-06-02 8:31 pm | Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark | 1,830 | $7.8023 | $14,278 | 43,609 (Direct) | View |
| 2023-04-17 Sale | 2023-04-18 7:00 pm | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 8,500 | $13.97 | $118,728 | 197,274 (Indirect Direct) | View |
| 2023-04-06 Sale | 2023-04-10 4:13 pm | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 8,500 | $12.01 | $102,085 | 205,774 (Indirect Direct) | View |
| 2023-03-06 Sale | 2023-03-08 4:29 pm | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks | 2,435 | $15.26 | $37,167 | 584,671 (Indirect Direct) | View |
| 2023-03-06 Sale | 2023-03-08 4:29 pm | Arcutis Biotherapeutics Inc. | ARQT | Burrows Scott L Chief Financial Officer | 291 | $15.26 | $4,442 | 59,115 (Direct) | View |
| 2023-03-06 Sale | 2023-03-08 4:28 pm | Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks | 851 | $15.26 | $12,989 | 59,962 (Direct) | View |
| 2023-03-06 Sale | 2023-03-08 4:26 pm | Arcutis Biotherapeutics Inc. | ARQT | Turney Patricia A. SVP, Operations | 831 | $15.26 | $12,684 | 62,862 (Direct) | View |
| 2023-03-06 Sale | 2023-03-08 4:26 pm | Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer | 690 | $15.26 | $10,532 | 268,854 (Direct) | View |
| 2023-03-06 Sale | 2023-03-08 4:25 pm | Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer | 831 | $15.26 | $12,684 | 63,429 (Direct) | View |
| 2023-03-02 Sale | 2023-03-06 6:54 pm | Arcutis Biotherapeutics Inc. | ARQT | Moore Matthew Richard See Remarks | 1,610 | $15.83 | $25,481 | 66,090 (Direct) | View |
| 2023-03-02 Sale | 2023-03-06 6:52 pm | Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remarks | 1,434 | $15.83 | $22,696 | 94,901 (Direct) | View |
| 2023-03-02 Sale | 2023-03-06 6:51 pm | Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks | 1,751 | $15.83 | $27,713 | 116,613 (Direct) | View |
| 2023-02-28 Sale | 2023-03-02 7:07 pm | Arcutis Biotherapeutics Inc. | ARQT | Turney Patricia A. SVP, Operations | 2,368 | $15.96 | $37,796 | 45,693 (Direct) | View |
| 2023-02-28 Sale | 2023-03-02 7:06 pm | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks | 7,815 | $15.93 | $124,483 | 587,106 (Indirect Direct) | View |
| 2023-02-28 Sale | 2023-03-02 7:05 pm | Arcutis Biotherapeutics Inc. | ARQT | Burrows Scott L Chief Financial Officer | 1,850 | $15.9 | $29,421 | 38,406 (Direct) | View |
| 2023-02-28 Sale | 2023-03-02 7:04 pm | Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer | 2,368 | $15.96 | $37,796 | 43,260 (Direct) | View |
| 2023-02-28 Sale | 2023-03-02 7:03 pm | Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer | 2,005 | $15.96 | $32,002 | 254,644 (Direct) | View |
| 2023-02-15 Sale | 2023-02-21 07:20 am | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 8,500 | $16.98 | $144,352 | 214,274 (Indirect Direct) | View |
| 2023-02-13 Sale | 2023-02-15 7:09 pm | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks | 1,000 | $17.01 | $17,012 | 594,921 (Indirect Direct) | View |
| 2023-02-01 Sale | 2023-02-03 4:26 pm | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks | 1,000 | $17 | $17,003 | 595,921 (Indirect Direct) | View |
| 2023-01-17 Sale | 2023-01-18 8:18 pm | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 8,500 | $13.72 | $116,655 | 222,774 (Indirect Direct) | View |
| 2023-01-03 Sale | 2023-01-04 5:15 pm | Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks | 1,475 | $15.01 | $22,136 | 41,564 (Direct) | View |
| 2022-12-07 Sale | 2022-12-09 4:47 pm | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks | 1,000 | $17.06 | $17,060 | 596,921 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-08-29 Option Award | 2023-09-12 07:39 am | N/A 2031-01-18 | Arcutis Biotherapeutics Inc. | ARQT | Moore Matthew Richard SVP and Chief Business Officer | 12,500 | $0 | 12,500 (Direct) | View |
| 2023-08-31 Option Award | 2023-09-05 9:38 pm | N/A 2033-08-31 | Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer | 125,000 | $0 | 125,000 (Direct) | View |
Ownership | 2023-09-05 9:36 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer | 0 | $0 | 253,738 (Indirect) | View |
| 2023-05-27 Option Award | 2023-06-02 8:31 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark | 4,875 | $0 | 43,609 (Direct) | View |
| 2023-05-31 Option Award | 2023-06-02 8:31 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark | 1,463 | $6.38 | 43,609 (Direct) | View |
| 2023-05-31 Option Award | 2023-06-02 7:22 pm | N/A 2033-05-31 | Arcutis Biotherapeutics Inc. | ARQT | LIN SUE-JEAN Director | 16,595 | $0 | 21,207 (Direct) | View |
| 2023-05-31 Option Award | 2023-06-02 7:16 pm | N/A 2033-05-31 | Arcutis Biotherapeutics Inc. | ARQT | Heron Patrick J Director 10% Owner | 16,595 | $0 | 20,907 (Direct) | View |
| 2023-05-31 Option Award | 2023-06-02 7:13 pm | N/A 2033-05-31 | Arcutis Biotherapeutics Inc. | ARQT | CHAUDHURI BHASKAR Director | 16,595 | $0 | 912,279 (Direct) | View |
| 2023-05-31 Option Award | 2023-06-02 7:10 pm | N/A 2033-05-31 | Arcutis Biotherapeutics Inc. | ARQT | Curran Terrie Director | 16,595 | $0 | 20,907 (Direct) | View |
| 2023-05-31 Option Award | 2023-06-02 7:08 pm | N/A 2033-05-31 | Arcutis Biotherapeutics Inc. | ARQT | Gilbert Halley E Director | 16,595 | $0 | 20,907 (Direct) | View |
| 2023-05-31 Option Award | 2023-06-02 7:02 pm | N/A 2033-05-31 | Arcutis Biotherapeutics Inc. | ARQT | Leonard Keith R Director | 16,595 | $0 | 22,657 (Direct) | View |
| 2023-05-31 Option Award | 2023-06-02 6:59 pm | N/A 2033-05-31 | Arcutis Biotherapeutics Inc. | ARQT | Krishnamohan Neha Director | 16,595 | $0 | 17,827 (Direct) | View |
| 2023-05-31 Option Award | 2023-06-02 6:54 pm | N/A 2033-05-31 | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 16,595 | $0 | 207,411 (Direct) | View |
| 2023-04-17 Exercise | 2023-04-18 7:00 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 8,500 | $1.6806 | 197,274 (Direct) | View |
| 2023-04-17 Exercise | 2023-04-18 7:00 pm | N/A 2029-03-13 | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 8,500 | $0 | 197,274 (Direct) | View |
| 2023-04-06 Exercise | 2023-04-10 4:13 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 8,500 | $1.6806 | 205,774 (Direct) | View |
| 2023-04-06 Exercise | 2023-04-10 4:13 pm | N/A 2029-03-13 | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 8,500 | $0 | 205,774 (Direct) | View |
| 2023-03-02 Option Award(A) | 2023-03-31 9:54 pm | N/A 2033-03-02 | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks | 319,500 | $0 | 688,592 (Direct) | View |
| 2023-03-02 Option Award | 2023-03-06 6:58 pm | N/A 2033-03-02 | Arcutis Biotherapeutics Inc. | ARQT | Burrows Scott L Chief Financial Officer | 76,800 | $0 | 115,206 (Direct) | View |
| 2023-03-02 Option Award | 2023-03-06 6:57 pm | N/A 2033-03-02 | Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer | 76,800 | $0 | 120,060 (Direct) | View |
| 2023-03-02 Option Award | 2023-03-06 6:56 pm | N/A 2033-03-02 | Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer | 54,400 | $0 | 309,044 (Direct) | View |
| 2023-03-02 Option Award | 2023-03-06 6:55 pm | N/A 2033-03-02 | Arcutis Biotherapeutics Inc. | ARQT | Turney Patricia A. SVP, Operations | 65,600 | $0 | 111,293 (Direct) | View |
| 2023-03-02 Option Award | 2023-03-06 6:54 pm | N/A 2033-03-02 | Arcutis Biotherapeutics Inc. | ARQT | Moore Matthew Richard See Remarks | 54,400 | $0 | 66,090 (Direct) | View |
| 2023-03-02 Option Award | 2023-03-06 6:52 pm | N/A 2033-03-02 | Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remarks | 76,800 | $0 | 94,901 (Direct) | View |
| 2023-03-02 Option Award | 2023-03-06 6:51 pm | N/A 2033-03-02 | Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks | 76,800 | $0 | 116,613 (Direct) | View |
| 2023-02-15 Exercise | 2023-02-21 07:20 am | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 8,500 | $1.6806 | 214,274 (Direct) | View |
| 2023-02-15 Exercise | 2023-02-21 07:20 am | N/A 2029-03-13 | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 8,500 | $0 | 214,274 (Direct) | View |
| 2023-01-17 Exercise | 2023-01-18 8:18 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 8,500 | $1.68 | 222,774 (Direct) | View |
| 2023-01-17 Exercise | 2023-01-18 8:18 pm | N/A 2029-03-13 | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 8,500 | $0 | 222,774 (Direct) | View |